Back to Search
Start Over
Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
- Source :
-
The American journal of cardiology [Am J Cardiol] 2019 Nov 15; Vol. 124 (10), pp. 1584-1589. Date of Electronic Publication: 2019 Aug 22. - Publication Year :
- 2019
-
Abstract
- Heart failure with preserved ejection fraction (HFpEF) is frequently accompanied by co-morbidities and a systemic proinflammatory state, resulting in coronary microvascular dysfunction (CMD), as well as myocardial fibrosis. The purpose of this study is to examine the relation between myocardial perfusion reserve (MPR) and diffuse myocardial fibrosis in patients with HFpEF using cardiovascular magnetic resonance. A single center study was performed in 19 patients with clinical HFpEF and 15 healthy control subjects who underwent quantitative first-pass perfusion imaging to calculate global MPR. T1 mapping was used to assess fibrosis and to calculate extracellular volume. Spiral cine displacement encoded stimulated echo was used to calculate myocardial strain. Comprehensive 2D echocardiograms with speckle tracking, cardiopulmonary exercise testing, and brain natriuretic peptide levels were also obtained. In patients with HFpEF, mean left ventricular EF was 61% ± 9% and left ventricular mass index 45 ± 12 g/m <superscript>2</superscript> . Compared with controls, HFpEF patients had reduced global MPR (2.29 ± 0.64 vs 3.38 ± 0.76, p = 0.002) and VO <subscript>2</subscript> max (16.5 ± 6.8 vs 30.9 ± 7.7 ml/kg min, p <0.001) whereas extracellular volume (0.29 ± 0.04 vs 0.25 ± 0.04, p = 0.02), pulmonary artery systolic pressure (35.4 ± 13.7 vs 22.3 ± 5.4 mm Hg, p = 0.004), and average E/e' (15.0 ± 7.6 vs 8.6 ± 2.0, p = 0.005) were increased. Displacement encoded stimulated echo peak systolic circumferential strain (p = 0.60) as well as echocardiographic derived global longitudinal strain (p = 0.07) were similar between both groups. The prevalence of CMD, defined as global MPR <2.5, in the HFpEF group was 69%. In conclusion, HFpEF patients have a high prevalence of CMD and diffuse fibrosis. These parameters may be useful clinical end points for future therapeutic trials.<br /> (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Subjects :
- Aged
Cardiomyopathies epidemiology
Cardiomyopathies physiopathology
Comorbidity
Coronary Artery Disease diagnosis
Coronary Artery Disease physiopathology
Female
Fibrosis diagnosis
Fibrosis epidemiology
Fibrosis physiopathology
Heart Failure diagnosis
Heart Failure epidemiology
Heart Ventricles diagnostic imaging
Humans
Incidence
Male
Microcirculation physiology
Middle Aged
Myocardium pathology
Prevalence
United States epidemiology
Ventricular Function, Left
Cardiomyopathies diagnosis
Coronary Artery Disease epidemiology
Coronary Circulation physiology
Heart Failure physiopathology
Heart Ventricles physiopathology
Magnetic Resonance Imaging, Cine methods
Stroke Volume physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1913
- Volume :
- 124
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- The American journal of cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 31575425
- Full Text :
- https://doi.org/10.1016/j.amjcard.2019.08.011